Sparsentan new drug for kidney disease

Sparsentan (Sparsentan) is an innovative drug mainly used to treat primary immunoglobulin A nephropathy (IgAN), a chronic kidney disease characterized by the deposition of immunoglobulin A in the kidneys. Sparsentan is a dual antagonist of endothelin-1 receptor A (ETₐR) and angiotensin II type 1 receptor (AT₁R). It regulates the physiological functions of the kidney by antagonizing both receptors at the same time.

ForIgAN patients, especially those adults with a higher risk of rapid disease progression (urinary protein to creatinine ratio ≥1.5g/g), sparsentan has shown significant therapeutic effects. Clinical trial data show that the drug can effectively reduce proteinuria, protect kidney function, and delay the progression of nephritis.

Drug research and development is based on in-depth research on the pathophysiological mechanisms of nephritis. Sparsentan has been proven safe and effective through rigorous clinical trials. However, like other drugs, it may also produce some side effects, such as peripheral edema, hypotension, etc., so you must follow your doctor's advice when using it.

As the number of kidney disease patients increases globally, the need for effective treatments becomes increasingly urgent. As a new and highly effective therapeutic drug, sparsentan has broad market prospects. Currently, the drug has been launched in the United States and other places, providing new treatment options for more patients. With its unique mechanism of action and significant therapeutic effect, sparsentane has shown great potential in the field of nephritis treatment.

Because Sparsentan has not yet been officially launched in China, patients cannot purchase it through domestic channels yet. We learned from relevant resources that each box of the original overseas Sparsentan contains 30 200mg tablets, and the price is around 10,000 yuan. This price will fluctuate according to changes in exchange rates. At the same time, Lucius Pharmaceuticals of Laos also produces sparsentane, and its price of 400 mg and 30 tablets is about 7,800 yuan. For more questions about sparsentine, patients can consult a medical professional consultant.